Literature DB >> 11487614

Amphetamine distorts stimulation-dependent dopamine overflow: effects on D2 autoreceptors, transporters, and synaptic vesicle stores.

Y Schmitz1, C J Lee, C Schmauss, F Gonon, D Sulzer.   

Abstract

Amphetamine (AMPH) is known to raise extracellular dopamine (DA) levels by inducing stimulation-independent DA efflux via reverse transport through the DA transporter and by inhibiting DA re-uptake. In contrast, recent studies indicate that AMPH decreases stimulation-dependent vesicular DA release. One candidate mechanism for this effect is the AMPH-mediated redistribution of DA from vesicles to the cytosol. In addition, the inhibition of stimulation-dependent release may occur because of D2 autoreceptor activation by DA that is released via reverse transport. We used the D2 receptor antagonist sulpiride and mice lacking the D2 receptor to address this issue. To evaluate carefully AMPH effects on release and uptake, we recorded stimulated DA overflow in striatal slices by using continuous amperometry and cyclic voltammetry. Recordings were fit by a random walk simulation of DA diffusion, including uptake with Michaelis-Menten kinetics, that provided estimates of DA concentration and uptake parameters. AMPH (10 microm) promoted the overflow of synaptically released DA by decreasing the apparent affinity for DA uptake (K(m) increase from 0.8 to 32 microm). The amount of DA released per pulse, however, was decreased by 82%. This release inhibition was prevented partly by superfusion with sulpiride (47% inhibition) and was reduced in D2 mutant mice (23% inhibition). When D2 autoreceptor activation was minimal, the combined effects of AMPH on DA release and uptake resulted in an enhanced overflow of exocytically released DA. Such enhancement of stimulation-dependent DA overflow may occur under conditions of low D2 receptor activity or expression, for example as a result of AMPH sensitization.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11487614      PMCID: PMC6763160     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  49 in total

1.  Differential autoreceptor control of somatodendritic and axon terminal dopamine release in substantia nigra, ventral tegmental area, and striatum.

Authors:  S J Cragg; S A Greenfield
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

2.  Dopamine levels of two classes of vesicles are differentially depleted by amphetamine.

Authors:  B B Anderson; G Chen; D A Gutman; A G Ewing
Journal:  Brain Res       Date:  1998-03-30       Impact factor: 3.252

Review 3.  A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants.

Authors:  R C Pierce; P W Kalivas
Journal:  Brain Res Brain Res Rev       Date:  1997-10

4.  Diffusion of albumins in rat cortical slices and relevance to volume transmission.

Authors:  L Tao; C Nicholson
Journal:  Neuroscience       Date:  1996-12       Impact factor: 3.590

5.  Dopamine neuronal transport kinetics and effects of amphetamine.

Authors:  S R Jones; J D Joseph; L S Barak; M G Caron; R M Wightman
Journal:  J Neurochem       Date:  1999-12       Impact factor: 5.372

6.  Ascorbate inhibits edema in brain slices.

Authors:  B Brahma; R E Forman; E E Stewart; C Nicholson; M E Rice
Journal:  J Neurochem       Date:  2000-03       Impact factor: 5.372

7.  Voltage-dependent calcium channels in rat midbrain dopamine neurons: modulation by dopamine and GABAB receptors.

Authors:  D L Cardozo; B P Bean
Journal:  J Neurophysiol       Date:  1995-09       Impact factor: 2.714

8.  Synaptic concentration of dopamine in the mouse striatum in relationship to the kinetic properties of the dopamine receptors and uptake mechanism.

Authors:  S B Ross
Journal:  J Neurochem       Date:  1991-01       Impact factor: 5.372

9.  Amphetamine attenuates the stimulated release of dopamine in vivo.

Authors:  W G Kuhr; A G Ewing; J A Near; R M Wightman
Journal:  J Pharmacol Exp Ther       Date:  1985-02       Impact factor: 4.030

10.  Amphetamine levels in brain microdialysate, caudate/putamen, substantia nigra and plasma after dosage that produces either behavioral or neurotoxic effects.

Authors:  P Clausing; B Gough; R R Holson; W Slikker; J F Bowyer
Journal:  J Pharmacol Exp Ther       Date:  1995-08       Impact factor: 4.030

View more
  80 in total

1.  Methamphetamine alters vesicular monoamine transporter-2 function and potassium-stimulated dopamine release.

Authors:  Pei-Wen Chu; Gregory C Hadlock; Paula Vieira-Brock; Kristen Stout; Glen R Hanson; Annette E Fleckenstein
Journal:  J Neurochem       Date:  2010-08-25       Impact factor: 5.372

2.  Role of aberrant striatal dopamine D1 receptor/cAMP/protein kinase A/DARPP32 signaling in the paradoxical calming effect of amphetamine.

Authors:  Francesco Napolitano; Alessandra Bonito-Oliva; Mauro Federici; Manolo Carta; Francesco Errico; Salvatore Magara; Giuseppina Martella; Robert Nisticò; Diego Centonze; Antonio Pisani; Howard H Gu; Nicola B Mercuri; Alessandro Usiello
Journal:  J Neurosci       Date:  2010-08-18       Impact factor: 6.167

3.  Modafinil augments brain activation associated with reward anticipation in the nucleus accumbens.

Authors:  Takuya Funayama; Yumiko Ikeda; Amane Tateno; Hidehiko Takahashi; Yoshiro Okubo; Haruhisa Fukayama; Hidenori Suzuki
Journal:  Psychopharmacology (Berl)       Date:  2014-02-28       Impact factor: 4.530

Review 4.  The need for speed: an update on methamphetamine addiction.

Authors:  Alasdair M Barr; William J Panenka; G William MacEwan; Allen E Thornton; Donna J Lang; William G Honer; Tania Lecomte
Journal:  J Psychiatry Neurosci       Date:  2006-09       Impact factor: 6.186

5.  Repeated exposure to methamphetamine causes long-lasting presynaptic corticostriatal depression that is renormalized with drug readministration.

Authors:  Nigel S Bamford; Hui Zhang; John A Joyce; Christine A Scarlis; Whitney Hanan; Nan-Ping Wu; Véronique M André; Rachel Cohen; Carlos Cepeda; Michael S Levine; Erin Harleton; David Sulzer
Journal:  Neuron       Date:  2008-04-10       Impact factor: 17.173

Review 6.  Effects of prenatal methamphetamine exposure: a review of cognitive and neuroimaging studies.

Authors:  Maja A Kwiatkowski; Annerine Roos; Dan J Stein; Kevin G F Thomas; Kirsty Donald
Journal:  Metab Brain Dis       Date:  2013-12-28       Impact factor: 3.584

Review 7.  Linking nucleus accumbens dopamine and blood oxygenation.

Authors:  Brian Knutson; Sasha E B Gibbs
Journal:  Psychopharmacology (Berl)       Date:  2007-02-06       Impact factor: 4.530

8.  S(+)amphetamine induces a persistent leak in the human dopamine transporter: molecular stent hypothesis.

Authors:  Aldo A Rodriguez-Menchaca; Ernesto Solis; Krasnodara Cameron; Louis J De Felice
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

9.  Altered dopamine release and uptake kinetics in mice lacking D2 receptors.

Authors:  Yvonne Schmitz; Claudia Schmauss; David Sulzer
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

10.  Individual variation in incentive salience attribution and accumbens dopamine transporter expression and function.

Authors:  Bryan F Singer; Bipasha Guptaroy; Curtis J Austin; Isabella Wohl; Vedran Lovic; Jillian L Seiler; Roxanne A Vaughan; Margaret E Gnegy; Terry E Robinson; Brandon J Aragona
Journal:  Eur J Neurosci       Date:  2016-01-07       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.